Skip to main content

Table 3 Base case results representing an annual cohort from England (secondary outcomes)

From: A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients

Strategy

1(2)

2

3

4

5

6

7

8

Number of colonoscopies vs Strategy 1(1) (=4162)

+1618

+3044

+3008

+3401

+3381

+3381

+3842

+4400

Life expectancy of index patient vs Strategy 1(1) (=13.82 years)

+0.06

+0.10

+0.10

+0.12

+0.12

+0.12

+0.13

+0.14

Life expectancy of index patient with LS vs Strategy 1(1) (=12.93 years)

+0.72

+1.24

+1.24

+1.39

+1.39

+1.39

+1.56

+1.61

Life expectancy of relative vs Strategy 1(1) (=37.38 years)

+0.01

+0.05

+0.05

+0.05

+0.05

+0.05

+0.06

+0.06

Life expectancy of relative with LS vs Strategy 1(1) (=33.97 years)

+0.31

+1.24

+1.24

+1.39

+1.39

+1.39

+1.56

+1.61

Expected number of CRCs vs Strategy 1(1) (=664.9)

−8.36

−24.59

−24.56

−27.59

−27.57

−27.57

−30.95

−32.30

Expected number of ECs vs Strategy 1(1) (=53.8)

−4.99

−14.29

−14.29

−16.03

−16.03

−16.03

−17.97

−18.55

  1. Abbreviations: EC endometrial cancer.